Eric Guillemare

Introduction

Eric Guillemare is an accomplished inventor based in Nice, France, recognized for his significant contributions to the field of potassium channel research. With a total of two patents to his name, Guillemare has focused on advancements that could potentially impact drug screening and molecular biology.

Latest Patents

Guillemare's latest patents demonstrate his expertise in the cloning and application of a specific potassium channel known as TWIK-1. The first patent, titled "Isolated TWIK-1 potassium channel proteins," outlines the cloning of this newly identified potassium channel. This invention encompasses an isolated and purified nucleic acid molecule that codes for a protein exhibiting the properties and structure characteristic of TWIK-1. Additionally, this patent explores the implications of using this nucleic acid for cell transformation and the significant potential for drug screening using cells that express these potassium channels.

The second patent elaborates on the same innovative theme, described as "Family of mammalian potassium channels, their cloning and their use." This invention also details the isolated and purified nucleic acid molecule coding for TWIK-1 and its utility in biotechnology, particularly in transforming cells for proper research applications.

Career Highlights

Eric Guillemare is affiliated with the Centre National de la Recherche Scientifique (CNRS), a prominent research organization in France. His role in this institute has allowed him to delve deep into the complexities of potassium channels, contributing to a better understanding of cellular mechanisms.

Collaborations

Throughout his research journey, Guillemare has collaborated with notable peers, including Florian Lesage and Michel Fink. Together, they have worked to further the exploration of potassium channels, enhancing the collective understanding of their biological functions and implications in health and disease.

Conclusion

Eric Guillemare's innovative work in the cloning and application of potassium channel proteins underscores his impact on the field of molecular biology. As a vital part of the CNRS, his continued research promises to pave the way for new discoveries and advancements, particularly in drug screening technologies. Through his patents, Guillemare exemplifies the vital role of inventors in the ongoing quest for knowledge and innovation in scientific research.